This Week’s Biopharma News: New Pharma Legislation in Europe
December 16, 2025
Our latest news roundup reports on the oversubscribed financing for Cellular Origins, FDA approval for Amgen, CAR-T cell therapy outcomes, and more
5 min read
False
Advertisement
Latest
How Mixing FSP and FSO Models Bring Agility to Modern Clinical Development
By Les Enterline
December 15, 2025
Clinical trials are becoming longer, costlier and more complex, but a growing number of sponsors are finding agility in a hybrid approach.
4 min read
Scratching the Surface of Microneedle Array Patches
By Andrew Riso
December 12, 2025
Why the industry should open its eyes to the benefits of microneedle array patches for drug delivery.
5 min read
Outsmarting Cancer: The “Trojan Horse” of Gene Therapy
By Stephanie Vine
December 11, 2025
Borrowing strategy from ancient Greece, Trogenix hides its therapeutic warriors inside tumor cells. CEO Ken Macnamara discusses how.
5 min read
Rebuilding Confidence in UK Pharma Manufacturing
By Martyn Williams
December 11, 2025
The UK’s pharma manufacturing base still has potential, but only if companies modernize operations, boost efficiency, and show global investors that the UK can compete on cost and capability.
6 min read
This Week’s CGT News: Vertex’s Gene Therapies Show Promise in Younger Children
December 10, 2025
Our latest news roundup reports on new data for Vertex’s exa-cel, funding for a cell therapy for breast cancer, and new technologies for manufacturing
3 min read
DSCSA in Action: Real-World Lessons from US Supply Chain Implementation
By Matt Sample
December 9, 2025
After a decade of preparation, the US pharmaceutical supply chain has seamless, serialized traceability for every prescription drug. Here are my lessons learned during that process.
3 min read
Drug Delivery is Biotech’s Blind Spot. Here’s How we Fix it With Excipients
By Lisa Stehno-Bittel
December 8, 2025
Drug delivery innovation lags behind molecule discovery. Smarter polymer-based excipients can boost biologic stability, efficacy, and accessibility, transforming patient outcomes and biotech success.
3 min read
Making CAR T Truly Off the Shelf
By Hendrik Dietz
December 5, 2025
Could a single infusion transform a patient’s own T cells into cancer-fighting machines? Researchers are betting on single-stranded DNA and lipid nanoparticles to make in vivo CAR-T a scalable reality.
3 min read
For the Love of Patients: Communicate
By J.D. Mowery
December 4, 2025
So, you’re at the stage where you need a CDMO. Some partnerships work and others fail. Here’s what I’ve learned about trust from my experience.
5 min read
